Albert Boehringer

Boehringer Ingelheim

Boehringer Ingelheim is a rare case of sustained private ownership enabling both technical continuity (from lactic acid to biopharma) and social infrastructure (welfare policies pre-dating national systems). Its business model is not about disruption but compound discipline: owning the science, the scale, and the staff.